InvestorsHub Logo
Followers 1325
Posts 249266
Boards Moderated 57
Alias Born 12/07/2009

Re: jedijazz post# 4012

Thursday, 11/29/2012 7:43:50 AM

Thursday, November 29, 2012 7:43:50 AM

Post# of 4205
AMBS ~ Releases News & 8K on Positive Parkinson clinical studies.. AMBS is a Bullish Short Squeeze Play and 8K filed today mentions Upcoming FDA Phase I/II trials..
Must Read 8K from AMBS: AMBS 8K today filed stated, "The Independent Study indicates that MANF, the Company's (AMBS) leading drug candidate, diffuses from the point of delivery in the brain more favorably than GDNF; thus, providing a firm basis for the continue investment in MANF development. The next step in MANF development is clinical studies utilizing a primate model. If those studies are positive, they will be incorporated in the toxicological data of an investigational new drug application package to the FDA to be submitted prior to starting a Phase I/II clinical trial for MANF in the treatment of Parkinson's disease."
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.